semaglutide + cagrilintide Subcutaneous Cagrilintide, Shows Significant Weight Loss in Type 2 Diabetes Trial The next frontier in metabolic

of every kilo lost on a GLP-1 can be lean muscle not fat

Titration speed has no bearing on your final results

GHK-Cu has strong mechanistic and in-vitro data and several small human cosmetic studies, but no large randomized controlled trials comparable to tretinoin

Education 25(40):50 Mobasheri A, Rayman MP, Gualillo O, Sellam J, van der Kraan P, Fearon U (2017) The role of metabolism in the pathogenesis of osteoarthritis

Less fat means more visible muscle, a significant benefit for bodybuilders and athletes

GLP-1 medicines were originally developed as type 2 diabetes treatments, and they lower HbA1c (a three-month average of blood sugar) reliably and substantially, which is why they are prescribed for diabetes as well as weight